{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-25-009240","form_type":"8-K","ticker":"BGLC","cik":"0001737523","company_name":"BioNexus Gene Lab Corp","filed_at":"2025-12-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.283347+00:00","generated_at":"2026-05-16T12:00:33.368322+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"BioNexus Gene Lab Corp. shareholders elect all four director nominees and approve 2025 equity plan","bullets":["Directors re-elected: Su-Leng Tan Lee, Muhammad Azrul bin Abdul Hamid, Jook Yuen Low, Chee Keong Yap.","2025 Equity Incentive Plan approved with 966,759.8 votes for, 10,628.5 against.","JP Centurion & Partners PLT ratified as independent auditor for FY 2025.","Adjournment proposal approved if needed to solicit additional proxies.","All proposals passed; meeting held December 24, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-25-009240","json":"https://secwatch.observer/filing/0001477932-25-009240.json","markdown":"https://secwatch.observer/filing/0001477932-25-009240.md","text":"https://secwatch.observer/filing/0001477932-25-009240.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1737523/000147793225009240/0001477932-25-009240-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1737523/000147793225009240/bglc_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T12:00:33.368322+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}